Assessing the magnitude of reporting bias in trials of homeopathy: a cross-sectional study and meta-analysisGerald Gartlehner, Robert Emprechtinger, Marlene Hackl, Franziska L Jutz, Jacob E Gartlehner, Julian N Nonninger, Irma Klerings, Andreea Iulia Dobrescu
15 March 2022
Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping reviewJulian Hirt, Perrine Janiaud, Lars G. Hemkens
27 January 2022
Which actionable statements qualify as good practice statements In Covid-19 guidelines? A systematic appraisalOmar Dewidar, Tamara Lotfi, Miranda Langendam, Elena Parmelli, Zuleika Saz Parkinson, Karla Solo, Derek K Chu, Joseph L Mathew, Elie A Akl, Romina Brignardello-Petersen, Reem A Mustafa, Lorenzo Moja, Alfonso Iorio, Yuan Chi, Carlos Canelo-AybarSee the full list of authors
15 April 2022
Bayesian interpretation of p values in clinical trialsJohn Ferguson
23 September 2021
Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: a systematic review and meta-analysisNaomi Fujita-Rohwerder, Lars Beckmann, Yvonne Zens, Arpana Verma
18 January 2022
Kidney trajectory charts to assist general practitioners in the assessment of patients with reduced kidney function: a randomised vignette studyMichelle Guppy, Paul Glasziou, Elaine Beller, Richard Flavel, Jonathan E Shaw, Elizabeth Barr, Jenny Doust
21 December 2021
Adapt or die: how the pandemic made the shift from EBM to EBM+ more urgentTrisha Greenhalgh, David Fisman, Danielle J Cane, Matthew Oliver, Chandini Raina Macintyre
19 July 2022
Later is not necessarily better: limitations of survival analysis in studies of long-term drug treatment of psychiatric conditionsJoanna Moncrieff, Janus Christian Jakobsen, Max Bachmann
23 September 2021
Ivabradine added to usual care in patients with heart failure: a systematic review with meta-analysis and trial sequential analysisMathias Maagaard, Emil Eik Nielsen, Naqash Javaid Sethi, Ning Liang, Si-Hong Yang, Christian Gluud, Janus Christian Jakobsen
17 November 2021
Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysisRini Noviyani, Sitaporn Youngkong, Surakit Nathisuwan, Bhavani Shankara Bagepally, Usa Chaikledkaew, Nathorn Chaiyakunapruk, Gareth McKay, Piyamitr Sritara, John Attia, Ammarin Thakkinstian
11 October 2021